名称:抗PF4抗体(anti- PF4 antibody) 货号:FNab10918 适应种属:人源 规格:100ug(微克) 状态:液体 纯化方法:免疫亲和纯化 纯度:经sds-page分析,纯度大于95% 宿主:兔 亚型:IgG 存储:用添加了0.02%叠氮化钠和50%甘油的pbs溶解,ph值7.3,可在-20℃下保存12个月(避免反复冻融) ...
PF4/heparin antibody test is useful to ensure appropriate treatment for thrombocytopenic heparinized ICU patients.doi:10.5045/kjh.2012.47.1.39Park, Sang HyukJang, SeongsooShim, HyoeunPark, Geum-BoraePark, Chan-JeoungChi, Hyun-SookHong, Sang-Bum...
PF4/heparin antibody test is useful to ensure appropriate treatment for thrombocytopenic heparinized ICU patients. 展开 关键词: Intensive care units Platelet factor 4 Heparin Antibody Heparin-induced thrombocytopenia DOI: 10.5045/kjh.2012.47.1.39
Anti-PF4 antibody negative cerebral venous sinus thrombosis without thrombocytopenia following immunization with COVID-19 vaccine in an elderly non-comorbid Indian male, managed with conventional heparin-warfarin based anticoagulation Author links open overlay panelAjitavaDuttaaRitwikGhoshbDwaipayanBhattacharyaa...
4种IgG抗体亚型的区别: 英文名称 Anti-PRPF4图片 中文名称 PRPF4蛋白抗体 别名 HPRP4; HPRP4P; PRP4; PRP4 pre mRNA processing factor 4 homolog (yeast); PRP4/STK/WD splicing factor; Prp4p; U4/U6 small nucl
品牌 AntibodySystem 产品规格 100ug 有效成分含量 100% 是否进口 否 用途范围 仅供科研使用 产品类型 抗体 储存条件 在2至8°C下储存 保质期 12个月 产地 France 配送方式 物流 可售卖地 北京;天津;河北;山西;内蒙古;辽宁;吉林;黑龙江;上海;江苏;浙江;安徽;福建;江西;山东;河南;湖北;湖南;广东;...
Incidence and clinical relevance of anti-PF4/heparin antibodies before cardiac surgery In some patients, anti-PF4/H antibodies are already detectable before cardiac surgery. Whether preoperative presence of antibodies confers adverse prognosis and which particular antibody classes (IgG, IgA, IgM) might ...
世联博研公司现货供应MYBIOSOURCE INC.品牌订货号为MBS9372926的Plant Platelet Factor 4 Antibody (Anti-PF4) ELISA Kit from MYBIOSOURCE INC.产品
Cell pellets were incubated with APC anti-mouse Cd163 Monoclonal Antibody (eBioscience™, TNKUPJ) and FITC anti-mouse Mrc1 (Biolegend, 068C2) antibody on ice, in the dark, for 20 min. The cell pellets were re-suspended in 300 µL of flow buffer and filtered through a 40 μm mesh...
et al. First-line penpulimab (an anti-PD1 antibody) and anlotinib (an angiogenesis inhibitor) with nab-paclitaxel/gemcitabine (PAAG) in metastatic pancreatic cancer: a prospective, multicentre, biomolecular exploratory, phase II trial. Sig Transduct Target Ther 9, 143 (2024). https://doi.org/...